A875 Cells
€500.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The A875 cell line is a human melanoma cell line derived from a metastatic site in a 40-year-old female. Exhibiting morphological and growth characteristics typical of malignant melanoma, A875 has been extensively utilized in oncological research, particularly focusing on melanoma biology, mechanisms of metastasis, and therapeutic resistance. This cell line is characterized by its aggressive growth and metastatic potential, making it an excellent model for in vivo tumor growth and metastasis studies in xenograft settings. A875 cells are particularly valuable for investigating the molecular and genetic underpinnings of melanoma progression. Research involving this cell line includes studies on the roles of oncogenes, tumor suppressor genes, and various signaling pathways that are pivotal in cancer development and progression. The cell line has been used in the assessment of novel chemotherapeutic agents and targeted therapies, benefiting from its genetic alterations that mimic those found in human melanomas. Furthermore, A875 serves as a key model for evaluating immune response mechanisms to melanoma, due to its ability to elicit strong immune reactions, thus aiding in the development and testing of new immunotherapies. |
|---|---|
| Organism | Human |
| Tissue | Skin |
| Disease | Melanoma |
| Synonyms | A-875 |
Characteristics
| Age | 40 years |
|---|---|
| Gender | Female |
| Morphology | Polygonal |
| Growth properties | Adherent |
Regulatory Data
| Citation | A875 (Cytion catalog number 305099) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_4733 |
Biomolecular Data
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305099-080823 | Certificate of Analysis | 23. May. 2025 | 305099 |
| 305099-190525 | Certificate of Analysis | 21. Jul. 2025 | 305099 |
Material Transfer Agreement
If you intend to use Cytion cell lines solely for internal research at a single research site, please complete and sign our Material Transfer Agreement (MTA) and submit it along with your order.
For any commercial applications - including but not limited to fee-for-service work, quality control testing, product release, diagnostic use, or regulatory studies - please complete the Intended Use Form so we can prepare a suitable agreement tailored to your project.
Please note: The MTA applies only to certain cell lines. If this notice and the MTA document appear on a product page, the agreement is applicable. For cell lines not covered by the MTA, no reference to the agreement will be shown. The MTA is not valid for customers in the Americas, China, or Taiwan. Please contact our U.S. entity to receive the appropriate agreement.